{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T10:29:33Z","timestamp":1795170573145,"version":"4.10.3"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1035 Z1"],"award-info":[{"award-number":["SFB 1035 Z1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1123 A1\/A10"],"award-info":[{"award-number":["SFB1123 A1\/A10"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST409\/150-1 FUGG"],"award-info":[{"award-number":["INST409\/150-1 FUGG"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2145 SyNergy-ID 390857198"],"award-info":[{"award-number":["EXC 2145 SyNergy-ID 390857198"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1123 Z1"],"award-info":[{"award-number":["SFB1123 Z1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST409\/150-1 FUGG"],"award-info":[{"award-number":["INST409\/150-1 FUGG"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG INST 409\/209-1 FUGG"],"award-info":[{"award-number":["DFG INST 409\/209-1 FUGG"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC2145 SyNergy-ID 390857198"],"award-info":[{"award-number":["EXC2145 SyNergy-ID 390857198"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1035 B06 \/201302640"],"award-info":[{"award-number":["SFB1035 B06 \/201302640"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amyloid self-assembly is linked to numerous devastating cell-degenerative diseases. However, designing inhibitors of this pathogenic process remains a major challenge. Cross-interactions between amyloid-\u03b2 peptide (A\u03b2) and islet amyloid polypeptide (IAPP), key polypeptides of Alzheimer\u2019s disease (AD) and type 2 diabetes (T2D), have been suggested to link AD with T2D pathogenesis. Here, we show that constrained peptides designed to mimic the A\u03b2 amyloid core (ACMs) are nanomolar cross-amyloid inhibitors of both IAPP and A\u03b242 and effectively suppress reciprocal cross-seeding. Remarkably, ACMs act by co-assembling with IAPP or A\u03b242 into amyloid fibril-resembling but non-toxic nanofibers and their highly ordered superstructures. Co-assembled nanofibers exhibit various potentially beneficial features including thermolability, proteolytic degradability, and effective cellular clearance which are reminiscent of labile\/reversible functional amyloids. ACMs are thus promising leads for potent anti-amyloid drugs in both T2D and AD while the supramolecular nanofiber co-assemblies should inform the design of novel functional (hetero-)amyloid-based nanomaterials for biomedical\/biotechnological applications.<\/jats:p>","DOI":"10.1038\/s41467-022-32688-0","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T15:03:19Z","timestamp":1661439799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1345-1308","authenticated-orcid":false,"given":"Karin","family":"Ta\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice Dalla","family":"Volta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"El Bounkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Hille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X\u00e8nia","family":"Puig-Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ballmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8338-2232","authenticated-orcid":false,"given":"Simon","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3941-9007","authenticated-orcid":false,"given":"Martin","family":"Ortner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Prem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Rammes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Haslbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9871-6696","authenticated-orcid":false,"given":"Remco T. A.","family":"Megens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2996-2652","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Bernhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6124-7232","authenticated-orcid":false,"given":"Aphrodite","family":"Kapurniotu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"32688_CR1","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1039\/C9CS00199A","volume":"49","author":"PC Ke","year":"2020","unstructured":"Ke, P. C. et al. Half a century of amyloids: past, present and future. Chem. Soc. Rev. 49, 5473\u20135509 (2020).","journal-title":"Chem. Soc. Rev."},{"key":"32688_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev. Biochem. 86, 27\u201368 (2017).","journal-title":"Annu Rev. Biochem."},{"key":"32688_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark, P., Andersson, A. & Westermark, G. T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 91, 795\u2013826 (2011).","journal-title":"Physiol. Rev."},{"key":"32688_CR4","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott, A. et al. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53, 1937\u20131942 (1999).","journal-title":"Neurology"},{"key":"32688_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/oxfordjournals.aje.a009106","volume":"145","author":"CL Leibson","year":"1997","unstructured":"Leibson, C. L. et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am. J. Epidemiol. 145, 301\u2013308 (1997).","journal-title":"Am. J. Epidemiol."},{"key":"32688_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1365-2125.2010.03830.x","volume":"71","author":"K Akter","year":"2011","unstructured":"Akter, K. et al. Diabetes mellitus and Alzheimer\u2019s disease: shared pathology and treatment? Br. J. Clin. Pharm. 71, 365\u2013376 (2011).","journal-title":"Br. J. Clin. Pharm."},{"key":"32688_CR7","doi-asserted-by":"crossref","unstructured":"Stanciu, G. D. et al. Link between diabetes and Alzheimer\u2019s disease due to the shared amyloid aggregation and deposition involving both neurodegenerative changes and neurovascular damages. J. Clin. Med. 9, 1713 (2020).","DOI":"10.3390\/jcm9061713"},{"key":"32688_CR8","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/mp.2016.230","volume":"22","author":"I Moreno-Gonzalez","year":"2017","unstructured":"Moreno-Gonzalez, I. et al. Molecular interaction between type 2 diabetes and Alzheimer\u2019s disease through cross-seeding of protein misfolding. Mol. Psychiatry 22, 1327\u20131334 (2017).","journal-title":"Mol. Psychiatry"},{"key":"32688_CR9","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","volume":"185","author":"ME Oskarsson","year":"2015","unstructured":"Oskarsson, M. E. et al. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease. Am. J. Pathol. 185, 834\u2013846 (2015).","journal-title":"Am. J. Pathol."},{"key":"32688_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"K Jackson","year":"2013","unstructured":"Jackson, K. et al. Amylin deposition in the brain: a second amyloid in Alzheimer disease? Ann. Neurol. 74, 517\u2013526 (2013).","journal-title":"Ann. Neurol."},{"key":"32688_CR11","doi-asserted-by":"publisher","first-page":"17490","DOI":"10.1074\/jbc.M311300200","volume":"279","author":"B O\u2019Nuallain","year":"2004","unstructured":"O\u2019Nuallain, B., Williams, A. D., Westermark, P. & Wetzel, R. Seeding specificity in amyloid growth induced by heterologous fibrils. J. Biol. Chem. 279, 17490\u201317499 (2004).","journal-title":"J. Biol. Chem."},{"key":"32688_CR12","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/anie.200604056","volume":"46","author":"LM Yan","year":"2007","unstructured":"Yan, L. M., Velkova, A., Tatarek-Nossol, M., Andreetto, E. & Kapurniotu, A. IAPP mimic blocks Abeta cytotoxic self-assembly: cross-suppression of amyloid toxicity of Abeta and IAPP suggests a molecular link between Alzheimer\u2019s disease and type II diabetes. Angew. Chem. Int. Ed. Engl. 46, 1246\u20131252 (2007).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"32688_CR13","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2174\/13816128113199990064","volume":"20","author":"LM Yan","year":"2014","unstructured":"Yan, L. M., Velkova, A. & Kapurniotu, A. Molecular characterization of the hetero-assembly of beta-amyloid peptide with islet amyloid polypeptide. Curr. Pharm. Des. 20, 1182\u20131191 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"32688_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ana.25668","volume":"87","author":"F Despa","year":"2020","unstructured":"Despa, F., Goldstein, L. B. & Biessels, G. J. Amylin as a potential link between type 2 diabetes and Alzheimer disease. Ann. Neurol. 87, 486 (2020).","journal-title":"Ann. Neurol."},{"key":"32688_CR15","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1096\/fj.201700431R","volume":"31","author":"N Wijesekara","year":"2017","unstructured":"Wijesekara, N. et al. Amyloid-beta and islet amyloid pathologies link Alzheimer\u2019s disease and type 2 diabetes in a transgenic model. FASEB J. 31, 5409\u20135418 (2017).","journal-title":"FASEB J."},{"key":"32688_CR16","doi-asserted-by":"publisher","first-page":"16485","DOI":"10.1074\/jbc.R116.714576","volume":"291","author":"J Luo","year":"2016","unstructured":"Luo, J., Warmlander, S. K., Graslund, A. & Abrahams, J. P. Cross-interactions between the Alzheimer disease amyloid-beta peptide and other amyloid proteins: a further aspect of the amyloid cascade hypothesis. J. Biol. Chem. 291, 16485\u201316493 (2016).","journal-title":"J. Biol. Chem."},{"key":"32688_CR17","doi-asserted-by":"crossref","first-page":"e12130","DOI":"10.1002\/trc2.12130","volume":"7","author":"H Ly","year":"2021","unstructured":"Ly, H. et al. The association of circulating amylin with beta-amyloid in familial Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 7, e12130 (2021).","journal-title":"Alzheimer\u2019s Dement."},{"key":"32688_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41594-020-00523-z","volume":"27","author":"A Kapurniotu","year":"2020","unstructured":"Kapurniotu, A. Enlightening amyloid fibrils linked to type 2 diabetes and cross-interactions with Abeta. Nat. Struct. Mol. Biol. 27, 1006\u20131008 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"32688_CR19","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1002\/anie.201906908","volume":"59","author":"V Armiento","year":"2020","unstructured":"Armiento, V., Spanopoulou, A. & Kapurniotu, A. Peptide-based molecular strategies to interfere with protein misfolding, aggregation, and cell degeneration. Angew. Chem. Int. Ed. Engl. 59, 3372\u20133384 (2020).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"32688_CR20","doi-asserted-by":"publisher","first-page":"13095","DOI":"10.1002\/anie.201504973","volume":"54","author":"E Andreetto","year":"2015","unstructured":"Andreetto, E. et al. A hot-segment-based approach for the design of cross-amyloid interaction surface mimics as inhibitors of amyloid self-assembly. Angew. Chem. Int. Ed. Engl. 54, 13095\u201313100 (2015).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"32688_CR21","doi-asserted-by":"publisher","first-page":"10378","DOI":"10.1002\/anie.201302840","volume":"52","author":"LM Yan","year":"2013","unstructured":"Yan, L. M. et al. Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Abeta40. Angew. Chem. Int. Ed. Engl. 52, 10378\u201310383 (2013).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"32688_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/13506129.2011.582902","volume":"18","author":"A Frydman-Marom","year":"2011","unstructured":"Frydman-Marom, A., Shaltiel-Karyo, R., Moshe, S. & Gazit, E. The generic amyloid formation inhibition effect of a designed small aromatic beta-breaking peptide. Amyloid 18, 119\u2013127 (2011).","journal-title":"Amyloid"},{"key":"32688_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18807-8","volume":"8","author":"A Franko","year":"2018","unstructured":"Franko, A. et al. Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice. Sci. Rep. 8, 1116 (2018).","journal-title":"Sci. Rep."},{"key":"32688_CR24","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1074\/jbc.M117.806109","volume":"293","author":"P Krotee","year":"2018","unstructured":"Krotee, P. et al. Common fibrillar spines of amyloid-beta and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors. J. Biol. Chem. 293, 2888\u20132902 (2018).","journal-title":"J. Biol. Chem."},{"key":"32688_CR25","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1002\/anie.200904902","volume":"49","author":"E Andreetto","year":"2010","unstructured":"Andreetto, E. et al. Identification of hot regions of the Abeta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association. Angew. Chem. Int. Ed. Engl. 49, 3081\u20133085 (2010).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"32688_CR26","doi-asserted-by":"publisher","first-page":"14587","DOI":"10.1074\/jbc.M117.774893","volume":"292","author":"M Bakou","year":"2017","unstructured":"Bakou, M. et al. Key aromatic\/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly. J. Biol. Chem. 292, 14587\u201314602 (2017).","journal-title":"J. Biol. Chem."},{"key":"32688_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41594-020-0435-3","volume":"27","author":"Q Cao","year":"2020","unstructured":"Cao, Q., Boyer, D. R., Sawaya, M. R., Ge, P. & Eisenberg, D. S. Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils. Nat. Struct. Mol. Biol. 27, 653\u2013659 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"32688_CR28","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41594-020-0442-4","volume":"27","author":"C Roder","year":"2020","unstructured":"Roder, C. et al. Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-beta fibrils. Nat. Struct. Mol. Biol. 27, 660\u2013667 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"32688_CR29","doi-asserted-by":"crossref","unstructured":"Gallardo, R. et al. Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly. Nat. Struct. Mol. Biol. 27, 1048\u20131056 (2020).","DOI":"10.1038\/s41594-020-0496-3"},{"key":"32688_CR30","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1110\/ps.036509.108","volume":"17","author":"JJ Wiltzius","year":"2008","unstructured":"Wiltzius, J. J. et al. Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin). Protein Sci. 17, 1467\u20131474 (2008).","journal-title":"Protein Sci."},{"key":"32688_CR31","doi-asserted-by":"publisher","first-page":"16742","DOI":"10.1073\/pnas.262663499","volume":"99","author":"AT Petkova","year":"2002","unstructured":"Petkova, A. T. et al. A structural model for Alzheimer\u2019s beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl Acad. Sci. USA 99, 16742\u201316747 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32688_CR32","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1073\/pnas.0507471103","volume":"103","author":"LM Yan","year":"2006","unstructured":"Yan, L. M., Tatarek-Nossol, M., Velkova, A., Kazantzis, A. & Kapurniotu, A. Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis. Proc. Natl Acad. Sci. USA 103, 2046\u20132051 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32688_CR33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nchem.1433","volume":"4","author":"PN Cheng","year":"2012","unstructured":"Cheng, P. N., Liu, C., Zhao, M., Eisenberg, D. & Nowick, J. S. Amyloid beta-sheet mimics that antagonize protein aggregation and reduce amyloid toxicity. Nat. Chem. 4, 927\u2013933 (2012).","journal-title":"Nat. Chem."},{"key":"32688_CR34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1021\/bi051952q","volume":"45","author":"AT Petkova","year":"2006","unstructured":"Petkova, A. T., Yau, W. M. & Tycko, R. Experimental constraints on quaternary structure in Alzheimer\u2019s beta-amyloid fibrils. Biochemistry 45, 498\u2013512 (2006).","journal-title":"Biochemistry"},{"key":"32688_CR35","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1021\/cn400141x","volume":"4","author":"WM Berhanu","year":"2013","unstructured":"Berhanu, W. M., Yasar, F. & Hansmann, U. H. In silico cross seeding of Abeta and amylin fibril-like oligomers. ACS Chem. Neurosci. 4, 1488\u20131500 (2013).","journal-title":"ACS Chem. Neurosci."},{"key":"32688_CR36","doi-asserted-by":"publisher","first-page":"23245","DOI":"10.1039\/C5CP03329B","volume":"17","author":"M Zhang","year":"2015","unstructured":"Zhang, M. et al. Polymorphic cross-seeding amyloid assemblies of amyloid-beta and human islet amyloid polypeptide. Phys. Chem. Chem. Phys. 17, 23245\u201323256 (2015).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"32688_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev.bi.47.070178.001343","volume":"47","author":"PY Chou","year":"1978","unstructured":"Chou, P. Y. & Fasman, G. D. Empirical predictions of protein conformation. Annu. Rev. Biochem. 47, 251\u2013276 (1978).","journal-title":"Annu. Rev. Biochem."},{"key":"32688_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/10409238009105470","volume":"8","author":"JA Smith","year":"1980","unstructured":"Smith, J. A. & Pease, L. G. Reverse turns in peptides and proteins. CRC Crit. Rev. Biochem. 8, 315\u2013399 (1980).","journal-title":"CRC Crit. Rev. Biochem."},{"key":"32688_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0065-3233(06)73003-0","volume":"73","author":"AV Kajava","year":"2006","unstructured":"Kajava, A. V. & Steven, A. C. Beta-rolls, beta-helices, and other beta-solenoid proteins. Adv. Protein Chem. 73, 55\u201396 (2006).","journal-title":"Adv. Protein Chem."},{"key":"32688_CR40","doi-asserted-by":"publisher","first-page":"8237","DOI":"10.1021\/bi002416v","volume":"40","author":"DJ Gordon","year":"2001","unstructured":"Gordon, D. J., Sciarretta, K. L. & Meredith, S. C. Inhibition of \u03b2-amyloid(40) fibrillogenesis and disassembly of \u03b2-amyloid(40) fibrils by short \u03b2-amyloid congeners containing N-methyl amino acids at alternate residues. Biochemistry 40, 8237\u20138245 (2001).","journal-title":"Biochemistry"},{"key":"32688_CR41","doi-asserted-by":"publisher","first-page":"25109","DOI":"10.1074\/jbc.M003554200","volume":"275","author":"E Hughes","year":"2000","unstructured":"Hughes, E., Burke, R. M. & Doig, A. J. Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25\u201335) using N-methylated derivatives: a general strategy to prevent amyloid formation. J. Biol. Chem. 275, 25109\u201325115 (2000).","journal-title":"J. Biol. Chem."},{"key":"32688_CR42","doi-asserted-by":"publisher","first-page":"9485","DOI":"10.1021\/bi0605585","volume":"45","author":"KL Sciarretta","year":"2006","unstructured":"Sciarretta, K. L., Boire, A., Gordon, D. J. & Meredith, S. C. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids. Biochemistry 45, 9485\u20139495 (2006).","journal-title":"Biochemistry"},{"key":"32688_CR43","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.1039\/C5AN00865D","volume":"140","author":"LM Young","year":"2015","unstructured":"Young, L. M. et al. Insights into the consequences of co-polymerisation in the early stages of IAPP and Abeta peptide assembly from mass spectrometry. Analyst 140, 6990\u20136999 (2015).","journal-title":"Analyst"},{"key":"32688_CR44","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1006\/jmbi.1999.2646","volume":"287","author":"R Kayed","year":"1999","unstructured":"Kayed, R. et al. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 287, 781\u2013796 (1999).","journal-title":"J. Mol. Biol."},{"key":"32688_CR45","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1016\/j.cell.2021.08.013","volume":"184","author":"MR Sawaya","year":"2021","unstructured":"Sawaya, M. R., Hughes, M. P., Rodriguez, J. A., Riek, R. & Eisenberg, D. S. The expanding amyloid family: Structure, stability, function, and pathogenesis. Cell 184, 4857\u20134873 (2021).","journal-title":"Cell"},{"key":"32688_CR46","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1021\/acschemneuro.8b00627","volume":"10","author":"AL Manchikalapudi","year":"2019","unstructured":"Manchikalapudi, A. L., Chilakala, R. R., Kalia, K. & Sunkaria, A. Evaluating the role of microglial cells in clearance of abeta from Alzheimer\u2019s brain. ACS Chem. Neurosci. 10, 1149\u20131156 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"32688_CR47","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters, S. L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat. Immunol. 11, 897\u2013904 (2010).","journal-title":"Nat. Immunol."},{"key":"32688_CR48","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9, 857\u2013865 (2008).","journal-title":"Nat. Immunol."},{"key":"32688_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.14573\/altex.2009.2.83","volume":"26","author":"A Henn","year":"2009","unstructured":"Henn, A. et al. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 26, 83\u201394 (2009).","journal-title":"ALTEX"},{"key":"32688_CR50","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1021\/acschemneuro.9b00260","volume":"10","author":"M Aftabizadeh","year":"2019","unstructured":"Aftabizadeh, M. et al. Blocking inflammasome activation caused by beta-amyloid peptide (Abeta) and islet amyloid polypeptide (IAPP) through an IAPP mimic. ACS Chem. Neurosci. 10, 3703\u20133717 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"32688_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12683-8","volume":"10","author":"M Kollmer","year":"2019","unstructured":"Kollmer, M. et al. Cryo-EM structure and polymorphism of Abeta amyloid fibrils purified from Alzheimer\u2019s brain tissue. Nat. Commun. 10, 4760 (2019).","journal-title":"Nat. Commun."},{"key":"32688_CR52","doi-asserted-by":"publisher","first-page":"17342","DOI":"10.1073\/pnas.0506723102","volume":"102","author":"T Luhrs","year":"2005","unstructured":"Luhrs, T. et al. 3D structure of Alzheimer\u2019s amyloid-beta(1-42) fibrils. Proc. Natl Acad. Sci. USA 102, 17342\u201317347 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32688_CR53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41594-018-0064-2","volume":"25","author":"EL Guenther","year":"2018","unstructured":"Guenther, E. L. et al. Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation. Nat. Struct. Mol. Biol. 25, 463\u2013471 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"32688_CR54","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1471-4159.2011.07506.x","volume":"120","author":"T Ma","year":"2012","unstructured":"Ma, T. & Klann, E. Amyloid \u03b2: linking synaptic plasticity failure to memory disruption in Alzheimer\u2019s disease. J. Neurochem. 120, 140\u2013148 (2012).","journal-title":"J. Neurochem."},{"key":"32688_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1750-1326-4-48","volume":"4","author":"GM Shankar","year":"2009","unstructured":"Shankar, G. M. & Walsh, D. M. Alzheimer\u2019s disease: synaptic function and A\u03b2. Mol. Neurodegener. 4, 48 (2009).","journal-title":"Mol. Neurodegener."},{"key":"32688_CR56","doi-asserted-by":"publisher","first-page":"8667","DOI":"10.1039\/C8CC02204F","volume":"54","author":"M Tornquist","year":"2018","unstructured":"Tornquist, M. et al. Secondary nucleation in amyloid formation. Chem. Commun. 54, 8667\u20138684 (2018).","journal-title":"Chem. Commun."},{"key":"32688_CR57","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/cbic.201000181","volume":"11","author":"M Suzuki","year":"2010","unstructured":"Suzuki, M. et al. Designed short peptides that form amyloid-like fibrils in coassembly with amyloid beta-peptide (Abeta) decrease the toxicity of Abeta to neuronal PC12 cells. Chembiochem 11, 1525\u20131530 (2010).","journal-title":"Chembiochem"},{"key":"32688_CR58","doi-asserted-by":"crossref","unstructured":"Chatani, E., Yuzu, K., Ohhashi, Y. & Goto, Y. Current understanding of the structure, stability and dynamic properties of amyloid fibrils. Int. J. Mol. Sci. 22, 4349 (2021).","DOI":"10.3390\/ijms22094349"},{"key":"32688_CR59","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12551-019-00526-1","volume":"11","author":"N Shanmugam","year":"2019","unstructured":"Shanmugam, N. et al. Microbial functional amyloids serve diverse purposes for structure, adhesion and defence. Biophysical Rev. 11, 287\u2013302 (2019).","journal-title":"Biophysical Rev."},{"key":"32688_CR60","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.1173155","volume":"325","author":"SK Maji","year":"2009","unstructured":"Maji, S. K. et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325, 328\u2013332 (2009).","journal-title":"Science"},{"key":"32688_CR61","doi-asserted-by":"publisher","first-page":"11473","DOI":"10.1021\/jacs.1c03392","volume":"143","author":"Y Cao","year":"2021","unstructured":"Cao, Y., Adamcik, J., Diener, M., Kumita, J. R. & Mezzenga, R. Different folding states from the same protein sequence determine reversible vs irreversible amyloid fate. J. Am. Chem. Soc. 143, 11473\u201311481 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"32688_CR62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3233\/JPD-202085","volume":"10","author":"T Werner","year":"2020","unstructured":"Werner, T., Horvath, I. & Wittung-Stafshede, P. Crosstalk between alpha-synuclein and other human and non-human amyloidogenic proteins: consequences for amyloid formation in Parkinson\u2019s disease. J. Parkinson\u2019s Dis. 10, 819\u2013830 (2020).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"32688_CR63","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1039\/C7CS00827A","volume":"47","author":"P Makam","year":"2018","unstructured":"Makam, P. & Gazit, E. Minimalistic peptide supramolecular co-assembly: expanding the conformational space for nanotechnology. Chem. Soc. Rev. 47, 3406\u20133420 (2018).","journal-title":"Chem. Soc. Rev."},{"key":"32688_CR64","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1046\/j.0014-2956.2001.02689.x","volume":"269","author":"A Kazantzis","year":"2002","unstructured":"Kazantzis, A., Waldner, M., Taylor, J. W. & Kapurniotu, A. Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt. Eur. J. Biochem. 269, 780\u2013791 (2002).","journal-title":"Eur. J. Biochem."},{"key":"32688_CR65","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/j.1742-4658.2008.06862.x","volume":"276","author":"DM Walsh","year":"2009","unstructured":"Walsh, D. M. et al. A facile method for expression and purification of the Alzheimer\u2019s disease-associated amyloid beta-peptide. FEBS J. 276, 1266\u20131281 (2009).","journal-title":"FEBS J."},{"key":"32688_CR66","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/nprot.2010.72","volume":"5","author":"A Jan","year":"2010","unstructured":"Jan, A., Hartley, D. M. & Lashuel, H. A. Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer\u2019s disease research. Nat. Protoc. 5, 1186\u20131209 (2010).","journal-title":"Nat. Protoc."},{"key":"32688_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19764-z","volume":"11","author":"C Kontos","year":"2020","unstructured":"Kontos, C. et al. Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting. Nat. Commun. 11, 5981 (2020).","journal-title":"Nat. Commun."},{"key":"32688_CR68","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1006\/jmbi.1999.3422","volume":"295","author":"K Tenidis","year":"2000","unstructured":"Tenidis, K. et al. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J. Mol. Biol. 295, 1055\u20131071 (2000).","journal-title":"J. Mol. Biol."},{"key":"32688_CR69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0076-6879(99)09021-7","volume":"309","author":"WE Klunk","year":"1999","unstructured":"Klunk, W. E., Jacob, R. F. & Mason, R. P. Quantifying amyloid by congo red spectral shift assay. Methods Enzymol. 309, 285\u2013305 (1999).","journal-title":"Methods Enzymol."},{"key":"32688_CR70","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/ATVBAHA.115.304875","volume":"35","author":"RT Megens","year":"2015","unstructured":"Megens, R. T., Bianchini, M., Schmitt, M. M. & Weber, C. Optical imaging innovations for atherosclerosis research: multiphoton microscopy and optical nanoscopy. Arterioscler. Thromb. Vasc. Biol. 35, 1339\u20131346 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"32688_CR71","doi-asserted-by":"publisher","first-page":"24765","DOI":"10.1074\/jbc.M111.329763","volume":"287","author":"AR Ladiwala","year":"2012","unstructured":"Ladiwala, A. R. et al. Conformational differences between two amyloid beta oligomers of similar size and dissimilar toxicity. J. Biol. Chem. 287, 24765\u201324773 (2012).","journal-title":"J. Biol. Chem."},{"key":"32688_CR72","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1021\/cn500014u","volume":"5","author":"PY Cho","year":"2014","unstructured":"Cho, P. Y., Joshi, G., Johnson, J. A. & Murphy, R. M. Transthyretin-derived peptides as beta-amyloid inhibitors. ACS Chem. Neurosci. 5, 542\u2013551 (2014).","journal-title":"ACS Chem. Neurosci."},{"key":"32688_CR73","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.neuropharm.2011.01.051","volume":"60","author":"G Rammes","year":"2011","unstructured":"Rammes, G., Hasenjager, A., Sroka-Saidi, K., Deussing, J. M. & Parsons, C. G. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of beta-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices. Neuropharmacology 60, 982\u2013990 (2011).","journal-title":"Neuropharmacology"},{"key":"32688_CR74","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuropharm.2014.12.037","volume":"92","author":"G Rammes","year":"2015","unstructured":"Rammes, G. et al. MRZ-99030 - A novel modulator of Abeta aggregation: II - Reversal of Abeta oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice. Neuropharmacology 92, 170\u2013182 (2015).","journal-title":"Neuropharmacology"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32688-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32688-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32688-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T05:26:16Z","timestamp":1700976376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32688-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["32688"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-32688-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"16 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.K., J.B., and K.T. are co-inventors of the European patent application 22 158 021.0 (applicant Technical University of Munich) (status: pending) related to ACMs, their hetero-assemblies, and potential biomedical applications. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5004"}}